Literature DB >> 1122342

[99mTc-sulfur-rhenium colloid and 111In-indium citrate in bone-marrow scintigraphy].

D Glaubitt, K Haberland, K Knoch, F L Fejér, S Zachariah.   

Abstract

Bone marrow scinitigraphy using 111In-Indium-citrate and 99mTc-sulfur rhenium colloid was compared with each other in 6 male and 3 female patients. Our results in all patients were in favour of 111In-citrate which caused a better delineation of morphological details than 99mTc-sulfur rhenium colloid did. In the first days after intravenous administration of 111In-citrate, radioindium accumulated markedly in the pudendal region, this finding being more distinct in male patients than in female ones. On account of these results a considerable radiation dose has to be assumed in bone marrow scinitigraphy using 111In-citrate as long as the absorbed dose from 111In has not been estimated under consideration of the radioindium accumulation in the pudendal region. 111In-citrate should be applied in bone marrow scanning only exceptionally and 99mTc-sulfur rhenium colloid be preferred in the routine diagnostics of bone marrow.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1122342     DOI: 10.1007/bf01633956

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  11 in total

1.  INTERNAL DOSE CALCULATION FOR 99MTC.

Authors:  E M SMITH
Journal:  J Nucl Med       Date:  1965-04       Impact factor: 10.057

2.  [Bone-marrow scintigraphy in patients with reticuloendothelial sarcoma].

Authors:  D Glaubitt; J Schneider; E Marx; H Schäfer; H Gerhartz; R Eigenbrod
Journal:  Verh Dtsch Ges Inn Med       Date:  1972

3.  Use of indium chloride scintigraphy in patients with myelofibrosis.

Authors:  B J McNeil; B L Holman; L N Button; D S Rosenthal
Journal:  J Nucl Med       Date:  1974-08       Impact factor: 10.057

4.  [Bone marrow scintigraphy using 99mTechnetium-sulfur-rhenium colloid in plasmacytoma patients].

Authors:  J Schneider; D Glaubitt; H Gerhartz
Journal:  Verh Dtsch Ges Inn Med       Date:  1973

5.  111 In-chloride: a new agent for bone marrow imaging.

Authors:  D L Lilien; H G Berger; D P Anderson; L R Bennett
Journal:  J Nucl Med       Date:  1973-03       Impact factor: 10.057

6.  Bone marrow and bone mineral scintigraphic studies in sickle cell disease.

Authors:  C F Hammel; S J DeNardo; G L DeNardo; J P Lewis
Journal:  Br J Haematol       Date:  1973-11       Impact factor: 6.998

7.  [First experiences with bone-marrow scintigraphy in the hospital].

Authors:  J Fischer; K H Brod; H Gamm; R Wolf
Journal:  Verh Dtsch Ges Inn Med       Date:  1971

8.  Estimates of absorbed fractions for monoenergetic photon sources uniformly distributed in various organs of a heterogeneous phantom.

Authors:  W S Snyder; H L Fisher; M R Ford; G G Warner
Journal:  J Nucl Med       Date:  1969-08       Impact factor: 10.057

9.  The quantitative distribution of the erythron and the RE cell in the bone marrow organ of man.

Authors:  W B Nelp; R E Bower
Journal:  Blood       Date:  1969-09       Impact factor: 22.113

10.  Differences in distribution of erythropoietic and reticuloendothelial marrow in hematologic disease.

Authors:  D Van Dyke; D Price; C Shkurkin; Y Yano; H O Anger
Journal:  Blood       Date:  1967-09       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.